UC San Diego Researchers Develop AI Model to Predict Cancer Treatment Response
Researchers at the University of California, San Diego have introduced a new artificial intelligence model named MutationProjector, designed to predict how tumors will respond to cancer treatments based on their genetic profiles. This model was developed by analyzing genomic data from over 30,000 tumors across ten different solid cancer types. The research, led by Trey Ideker, PhD, aims to improve the interpretation of genetic mutations in tumors, which is a critical step in determining effective cancer treatments. MutationProjector offers a comprehensive framework that connects cancer mutations to biological pathways, potentially enhancing the precision of treatment predictions. The model has been validated through testing on multiple independent patient cohorts, showing promise in predicting responses to both immunotherapy and chemotherapy. 
